Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

13G Filing: Rosalind Advisors, Inc. and Zosano Pharma Corp (NASDAQ:ZSAN)

Published on March 30, 2017 at 2:29 pm by Insider Monkey Staff in Hedge Funds

Page 8 of 9

Page 8 of 9 – SEC Filing


CUSIP No. 98979H103		13 G/A		Page 8 of 9 Pages


	(c)			Number of shares as to which the person has:

					(i)	Shared power to vote or to direct the vote Rosalind Advisors, Inc. – 2,083,100 Rosalind Master Fund L.P. – 584,761 Rosalind Capital Partners L.P. – 1,498,339 Steven Salamon – 2,083,100

					(ii)	Sole power to dispose or to direct the disposition of – 0

					(iii)	Shared power to dispose or to direct the disposition of Rosalind Advisors, Inc. – 2,083,100 Rosalind Master Fund L.P. – 584,761 Rosalind Capital Partners L.P. – 1,498,339 Steven Salamon – 2,083,100

Instruction.
For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

Item 5.	Ownership of Five Percent or Less of a Class.

If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following o.

Instruction.
Dissolution of a group requires a response to this item.

Item 6.	Ownership of More than Five Percent on Behalf of Another Person.

Item
7– 9.

Not
Applicable

Follow Zosano Pharma Corp (NASDAQ:ZSAN)

Follow Zosano Pharma Corp (NASDAQ:ZSAN)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 8 of 9

NASDAQ:ZSAN SEC 13G Filing Rosalind Advisors Steven Salamon Rosalind Advisors Zosano Pharma Corp (NASDAQ:ZSAN)